PMC:7402624 / 131-1408
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 289-293 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T2 | 300-304 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T3 | 371-375 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T4 | 431-442 | Body_part | denotes | plasmablast | http://purl.org/sig/ont/fma/fma84371 |
T5 | 484-489 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T6 | 521-531 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
12 | 26-31 | Species | denotes | human | Tax:9606 |
13 | 113-121 | Species | denotes | patients | Tax:9606 |
14 | 332-340 | Species | denotes | patients | Tax:9606 |
15 | 356-364 | Species | denotes | patients | Tax:9606 |
17 | 104-112 | Disease | denotes | COVID-19 | MESH:C000657245 |
18 | 411-426 | Disease | denotes | viral infection | MESH:D001102 |
19 | 898-906 | Disease | denotes | COVID-19 | MESH:C000657245 |
34 | 1031-1040 | Species | denotes | SARS-CoV2 | Tax:2697049 |
35 | 1051-1059 | Species | denotes | patients | Tax:9606 |
37 | 913-921 | Disease | denotes | COVID-19 | MESH:C000657245 |
38 | 961-971 | Disease | denotes | infections | MESH:D007239 |
39 | 998-1004 | Disease | denotes | deaths | MESH:D003643 |
40 | 1016-1025 | Disease | denotes | infection | MESH:D007239 |
41 | 1042-1050 | Disease | denotes | COVID-19 | MESH:C000657245 |
42 | 1262-1270 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T3 | 104-112 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 411-426 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T5 | 417-426 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 898-906 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 913-921 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T8 | 961-971 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 1016-1025 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T10 | 1031-1035 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 1042-1050 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 1262-1270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 3-4 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 26-31 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T3 | 56-61 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T4 | 273-283 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T5 | 287-293 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
T6 | 298-304 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cell |
T7 | 316-317 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 342-343 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T9 | 369-375 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
T10 | 376-386 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T11 | 482-489 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
T12 | 532-542 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T13 | 931-934 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 32-48 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
T2 | 369-386 | http://purl.obolibrary.org/obo/GO_0042110 | denotes | T cell activation |
T3 | 371-386 | http://purl.obolibrary.org/obo/GO_0001775 | denotes | cell activation |
T4 | 411-426 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
T5 | 521-542 | http://purl.obolibrary.org/obo/GO_0046649 | denotes | lymphocyte activation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 88-202 | Sentence | denotes | We analyzed 125 COVID-19 patients, and compared recovered to healthy individuals using high dimensional cytometry. |
T5 | 203-341 | Sentence | denotes | Integrated analysis of ~200 immune and ~50 clinical features revealed activation of T cell and B cell subsets in a proportion of patients. |
T6 | 342-490 | Sentence | denotes | A subgroup of patients had T cell activation characteristic of acute viral infection and plasmablast responses reaching >30% of circulating B cells. |
T7 | 491-577 | Sentence | denotes | However, another subgroup had lymphocyte activation comparable to uninfected subjects. |
T8 | 578-695 | Sentence | denotes | Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change. |
T9 | 696-809 | Sentence | denotes | These analyses identified three “immunotypes” associated with poor clinical trajectories versus improving health. |
T10 | 810-907 | Sentence | denotes | These immunotypes may have implications for the design of therapeutics and vaccines for COVID-19. |
T11 | 909-1005 | Sentence | denotes | The COVID-19 pandemic has to date caused >7 million infections resulting in over 400,000 deaths. |
T12 | 1006-1198 | Sentence | denotes | Following infection with SARS-CoV2, COVID-19 patients can experience mild or even asymptomatic disease, or can present with severe disease requiring hospitalization and mechanical ventilation. |
T13 | 1199-1249 | Sentence | denotes | The case fatality rate can be as high as ~10% (1). |